Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy

by Molassiotis, A., Cheng, H.L., Leung, K.T., Li, Y.C., Wong, K.H., Au, J.S.K., Sundar, R., Chan, A., Ng, T.R.D., Suen, L.K.P., Chan, C.W., Yorke, J., Lopez, V.
Published 2021

Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients rece...

by Molassiotis, A, Cheng, H.L, Lopez, V, Au, J.S.K, Chan, A, Bandla, A, Leung, K.T, Li, Y.C, Wong, K.H, Suen, L.K.P, Chan, C.W, Yorke, J, Farrell, C, Sundar, R
Published 2020

Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group - Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients tr...

by Cheng, H.L., Lopez, V., Lam, S.C., Leung, A.K.T., Li, Y.C., Wong, K.H., Au, J.S.K., Sundar, R., Chan, A., De Ng, T.R., Suen, L.K.P., Chan, C.W., Yorke, J., Molassiotis, A.
Published 2021